MOLPATH PRIVATE LIMITED

In their own words

At MOLPATH PRIVATE LIMITED, we are dedicated to advancing breast cancer therapy through innovative technology. Our primary focus is on the development and validation of a novel, non-invasive microfluidic platform for personalized drug screening. By combining genetic biomarkers with functional drug response assessments, our platform provides reliable predictions of drug efficacy and safety, enabling healthcare professionals to make more accurate and informed decisions regarding treatment.Our technology is designed to be portable and user-friendly, allowing for point-of-care use. This biocompatible, disposable device is uniquely QR-coded for each patient, ensuring a personalized approach to treatment. Incorporated under the Make-in-India initiative, it embodies our commitment to innovation and national self-reliance while offering a solution that is both effective and accessible to a wide range of patients. With our cutting-edge platform, we aim to transform the way breast cancer therapy is approached, making it more tailored and efficient. We are focused on improving patient outcomes by providing clinicians with precise tools to predict drug responses, ultimately enhancing the overall quality of care. At MOLPATH PRIVATE LIMITED, we strive to empower both healthcare providers and patients with personalized, data-driven insights that pave the way for better treatment strategies.

Written by the company on its public Startup India profile. Not verified by us.